$78.98
Fair Price Index
The fair price of a share represents the true value of the company's share based on its financial condition and performance. Unlike the current market price, which can fluctuate depending on the mood of the market, the fair price provides us with a better understanding of whether the share is truly advantageous.
To display the fair price of a share, you need to be a member of Bulios Black.
Profile
Ultragenyx Pharmaceutical is a biotechnology company focused on developing innovative therapeutic options for rare genetic diseases. The company specializes in developing drugs that target specific genetic mutations or metabolic pathways that cause various rare diseases, including genetic disorders that affect metabolism, growth, and development. Ultragenyx focuses on conditions for which there are limited available treatment options and strives to improve the lives of patients with these diseases.
Le stratège en chef des marchés mondiaux de J.P. Morgan, Marko Kolanovic, a décidé de réagir aux événements actuels du marché en affirmant que la hausse potentielle des taux n'est pas une source d'inquiétude pour les investisseurs. Dans le même temps, les analystes de J.P. Morgan ont pointé du doigt deux sociétés dont le cours a baissé et y voient une opportunité d'entrée.
